Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05897723 · ClinicalTrials.gov registry record · NA

Fractional Radiofrequency for Reduction of Surgical Scar Formation

A NA study of Surgical Incision, sponsored by Venus Concept.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05897723: Recruiting NA study of Surgical Incision, sponsored by Venus Concept.

NCT05897723 is a NA study of Surgical Incision that is actively recruiting participants, run by Venus Concept. The registered enrollment target is 20 participants, below the 157-participant average among 3 other Surgical Incision trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05897723, a NA study of Surgical Incision, is actively recruiting participants, sponsored by Venus Concept.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Safety and Efficacy of Fractional Radiofrequency for the Reduction of Surgical Scar Formation

Conditions Studied

Interventions

  • DEVICE Fractional Radiofrequency

Study Locations (1)

Texas

  • UT Southwestern Medical Center, Department of Plastic Surgery - Dallas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-09-01
Est. Completion 2025-12-31
Phase NA
Venus Concept

22 total trials

What NCT05897723 shows while recruiting

NCT05897723 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 157-participant average among 3 other Surgical Incision trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Surgical Incision appearing as the primary indexed condition, and to 1 intervention - of which Fractional Radiofrequency is the first listed.

NCT05897723 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05897723 about?

NCT05897723 is a clinical study titled "Fractional Radiofrequency for Reduction of Surgical Scar Formation". Safety and Efficacy of Fractional Radiofrequency for the Reduction of Surgical Scar Formation

What is the current status of trial NCT05897723?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-09-01. Estimated completion is 2025-12-31.

What conditions does trial NCT05897723 study?

This clinical trial studies the following conditions: Surgical Incision.

What interventions are being tested in trial NCT05897723?

The interventions under investigation include: Fractional Radiofrequency (DEVICE).

Who is sponsoring clinical trial NCT05897723?

This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05897723 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Incision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05897723, the US trial registry maintained by the National Library of Medicine. NCT05897723 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.